IDEXX Laboratories Reports Third-Quarter 2026 Revenue of $1.21 Billion
Revenue rose 9.9% year over year to $1.21 billion. Net income increased 15.5% to $317.15 million and diluted EPS rose 17.9% to $4.01; organic revenue growth was 10%, led by companion animal diagnostics.
IDEXX Laboratories reported third-quarter 2026 revenue of $1.21 billion, up 9.9% year over year, while net income rose 15.5% to $317.15 million and diluted EPS increased 17.9% to $4.01. Organic revenue growth was 10%, led by companion animal diagnostics.Financial Highlights¹ Reported as “Total reve…